LCC Appropriate Testing and Treatment of Stage IV NSCLC (Part 2 of 2 – Treatment)

LCC Appropriate Testing and Treatment of Stage IV NSCLC (Part 1 of 2 – Testing)Подробнее

Stage 2 Lung Adenocarcinoma: Biomarkers & Treatment Approaches - Case-Based Panel DiscussionsПодробнее

Detect Lung cancer earlyПодробнее

New Standard of care treatment for Small Cell lung cancer.Подробнее

Lung Cancer (Part 2) 2021Подробнее

Case 2: Treatment Considerations in Stage IV NSCLCПодробнее

Case 2: Frontline Treatment Data in Stage IV NSCLCПодробнее

LCC Treatment of Stage III & Stage IV NSCLC in the CommunityПодробнее

Lung Cancer Awareness part 2/5 - Molecular TestingПодробнее

5 Treatment Options for Small Cell Lung Cancer Part 2 #sharecare #shortsПодробнее

Case 2: Stage IV PD-L1–Negative, KRAS-Mutant Lung AdenocarcinomaПодробнее

Precision Oncology in Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the WayПодробнее

Understanding Lung Cancer Survival RateПодробнее

3 common myths about lung cancer w/ Dr. Eric SinghiПодробнее

Optimizing Advanced NSCLC Biomarker Testing, Treatment and Management Session 2Подробнее

Optimizing Biomarker Testing and Ensuring Appropriate Treatment of Metastatic NSCLCПодробнее

LCC Treatment of Resectable Stage III NSCLCПодробнее